You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 20, 2024

Invagen Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for INVAGEN PHARMS, and what generic and branded alternatives to INVAGEN PHARMS drugs are available?

INVAGEN PHARMS has sixty-one approved drugs.

There is one tentative approval on INVAGEN PHARMS drugs.

Summary for Invagen Pharms

US Patents:	0
Tradenames:	52
Ingredients:	52
NDAs:	61

Drugs and US Patents for Invagen Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Invagen Pharms	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	078457-004	Aug 24, 2007		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Invagen Pharms	HYDRALAZINE HYDROCHLORIDE	hydralazine hydrochloride	TABLET;ORAL	090255-004	Dec 15, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Invagen Pharms	LANREOTIDE ACETATE	lanreotide acetate	SOLUTION;SUBCUTANEOUS	215395-001	Dec 17, 2021		RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Invagen Pharms	QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; quinapril hydrochloride	TABLET;ORAL	201356-001	Apr 20, 2011		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Invagen Pharms	ZONISAMIDE	zonisamide	CAPSULE;ORAL	077869-003	May 31, 2006	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Invagen Pharms	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	204846-004	Jan 9, 2017		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Invagen Pharms

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Invagen Pharms	LEUPROLIDE ACETATE FOR DEPOT SUSPENSION	leuprolide acetate	FOR SUSPENSION;INTRAMUSCULAR	205054-001	Aug 28, 2018	9,789,064	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.